← back to search

Balázs Ács

Karolinska University Hospital · SE
Area of research
Oncology · Cancer Research
Research interest
Research interests include Breast Cancer Treatment Studies, Radiomics and Machine Learning in Medical Imaging, AI in cancer detection, and Cancer Immunotherapy and Biomarkers.
h-index
29
citations
4,068
works
199
NIH funding
primary concept
Medicine
email

Recent publications

Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma
JAMA Network Open 2025cited by 10position: lastdoi
Real-world overall survival and characteristics of patients with ER-zero and ER-low HER2-negative breast cancer treated as triple-negative breast cancer: a Swedish population-based cohort study
The Lancet Regional Health - Europe 2024cited by 38position: firstdoi
Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer
The Journal of Pathology 2024cited by 16position: middledoi
Ensemble-based deep learning improves detection of invasive breast cancer in routine histopathology images
Heliyon 2024cited by 14position: middledoi
The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?
EClinicalMedicine 2024cited by 14position: lastdoi
Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer
The Journal of Pathology 2023cited by 49position: middledoi
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer
The Journal of Pathology 2023cited by 49position: middledoi
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study
Modern Pathology 2022cited by 49position: firstdoi
Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Clinical Cancer Research 2022cited by 40position: middledoi
Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms
EBioMedicine 2022cited by 33position: middledoi
Improved breast cancer histological grading using deep learning
Annals of Oncology 2021cited by 208position: middledoi
Predicting Molecular Phenotypes from Histopathology Images: A Transcriptome-Wide Expression–Morphology Analysis in Breast Cancer
Cancer Research 2021cited by 90position: middledoi
Variability in Breast Cancer Biomarker Assessment and the Effect on Oncological Treatment Decisions: A Nationwide 5-Year Population-Based Study
Cancers 2021cited by 69position: firstdoi
An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer
Clinical Cancer Research 2021cited by 64position: middledoi
Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanoma
Scientific Reports 2021cited by 26position: middledoi
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
JNCI Journal of the National Cancer Institute 2020cited by 712position: middledoi
Artificial intelligence as the next step towards precision pathology
Journal of Internal Medicine 2020cited by 443position: firstdoi
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group
npj Breast Cancer 2020cited by 166position: middledoi
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
npj Breast Cancer 2020cited by 19position: middledoi
Deep Learning Based on Standard H&E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and Death
Clinical Cancer Research 2019cited by 124position: middledoi
An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma
Nature Communications 2019cited by 103position: firstdoi
Quantitative assessment of PD-L1 as an analyte in immunohistochemistry diagnostic assays using a standardized cell line tissue microarray
Laboratory Investigation 2019cited by 66position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Johan Hartman · Karolinska University Hospital9 papers (2020–2024)David L. Rimm · Yale Cancer Center7 papers (2019–2024)Mattias Rantalainen · Karolinska Institutet4 papers (2020–2024)Ana Bosch · Lund University3 papers (2021–2024)Anna Ehinger · Lund University3 papers (2021–2024)Sandra Martínez-Morilla · Yale Cancer Center3 papers (2019–2022)Yalai Bai · Yale Cancer Center3 papers (2021–2024)Roberto Salgado · Université Libre de Bruxelles2 papers (2020–2024)Robyn D. Gartrell · Columbia University2 papers (2019–2019) · 2 papers (2019–2019)Fahad Shabbir Ahmed · Indiana University School of Medicine2 papers (2019–2021)Yinxi Wang · Karolinska Institutet2 papers (2021–2021)Pok Fai Wong · AbbVie (United States)2 papers (2019–2019)Johan Staaf · University of Oslo2 papers (2021–2024)Stephanie Robertson · Karolinska Institutet2 papers (2021–2024) · 2 papers (2022–2024) · 2 papers (2019–2019)Jonas Bergh · Karolinska Institutet2 papers (2021–2022)Leslie Solorzano · Karolinska Institutet2 papers (2021–2024)Yvonne M. Saenger · NewYork–Presbyterian Hospital2 papers (2019–2019)